chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Seen at around 11:30 for WCC received  2 vaccines - meningococcal B and Menveo . Patient stated and waited 15minutes after vaccines administered. Patient left office and denied any signs or symptoms of reaction. Mom states on way home he complained his left arm felt sore. This was the arm he received the MenB in.  He did feel nauseated at the time. Mom states he took at nap when getting home. Later in the afternoon around  4:10 he begin to vomit and he passed out. His older sibling call 911 and EMT came and checked him out. Pt vomited again while EMT was present but vitals were WNL and patient  was fine. Patient complained of headache the remainder of the day.
Lightheaded; Chills; Muscles are sore; Fever; Arm is really sore; This is a spontaneous report from a contactable consumer. A 56-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER8736, NDC number and Expiry date: unknown) via an unspecified route of administration on 26Apr2021 at 08:50 or 08:55 (at the age of 56-year-old) in right arm as dose 1, single for covid-19 immunisation. Patient had received the vaccination at clinic. Medical history included immune system disorder, hot flush, hair disorder all from an unknown date and unknown if ongoing. Patient did not administer any additional vaccines and did not have any prior vaccinations within 4 weeks. Patient reported that she had soreness of the arm following the previous vaccination (Vaccine/Brand Name: Shingles vaccine, manufacturer unknown, vaccination date: Jan2021). Concomitant medications included biotin (BIOTIN) taken for hair disorder, start and stop date were not reported; elderberry [sambucus nigra] (ELDERBERRY [SAMBUCUS NIGRA]) taken for immune system disorder from an unspecified start date and ongoing; curcuma longa (TURMERIC [CURCUMA LONGA]) taken for immune system disorder from an unspecified start date and ongoing; zingiber officinale (GINGER [ZINGIBER OFFICINALE]) taken for immune system disorder, hot flush from an unspecified start date and ongoing. Caller reported that she has been taking all the medication for over a year. On 26Apr2021 the patient experienced chills, lightheaded, muscles were sore, fever and arm was really sore. It was reported that her muscles were sore, and she had fever in the middle of the night on 26Apr2021. Inquired if the chills, light-headedness, sore muscles, and fever were symptoms that were normal for the Covid-19 vaccine. She reported that her chills were little better but still there, light-headedness was little worse. Caller reported that she doesn't think that she had fever at time of call on 27Apr2021. Caller reported that she was pretty sure that she had fever last night on 26Apr2021, but she didn't take her temperature, reported later in the call that her arm was really sore from the Covid-19 vaccine. Caller reported that she was not looking forward to the second dose of the Covid-19 vaccine. The outcome of the events chills and pain in extremity was recovering, dizziness and myalgia was not recovered whereas for fever was unknown.  No follow-up attempts are needed. No further information is expected.
After receiving the vaccine the gentleman fainted and  hit the ground + broke glasses.   Young gentleman fainted in his chair during  observation, fell right out of his chair & hit hard Seemed very moveable Had a large red spot on his face from hitting  the ground.  He said he was okay & his  skin is sensitive Regularly  passes out when blood is drown     scared of needles Called his parents for a ride home Has gotten light headed after other shots
Initial report received from a licensed Practical Nurse on 06/Feb/2006. A 29-year-old female patient developed a "large swollen left arm" two days after receiving the intramuscular injection of DECAVAN, lot number U1636CA (expiry date 08/Jun/2007) on 01/Feb/2006. The patient received immunization at her routine physical and had no illness at the time. Treatment and recovery status was not reported.
After left the clinic - 35 minutes post injection felt lightheaded, warm and some chest pressure.  Clinic had ended.  Sent to the ED for evaluation.  EKG and Chest xray done - within normal limits.  Discharged from the ED  with a discharge note of likely vasovagal response
brutal shot, couldn't use arm for 4 days; This case was reported by a consumer via interactive digital media and described the occurrence of injected limb mobility decreased in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced injected limb mobility decreased. On an unknown date, the outcome of the injected limb mobility decreased was recovered/resolved.   It was unknown if the reporter considered the injected limb mobility decreased to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient received the brutal shingles shot and patient could not use that arm for 4 days. As per the patient, worth the shot though. For the another dose, refer linked case US2021AMR224145, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR224145:Same patient, same reporter, differnet dose (2nd dose)
nauseated, wheezy x 24 hrs, fatigue; sought no tx-resolved on its own; fine after 24 hrs; MD advised cont series to completion;
Later that day my arm was sore and the next morning around 7am i felt fatigue i was chill and temperature of 100 and slept througout the day and two days later i felt fatigue and really tired and day 3 i started having more energy.
Felt "tingling" after injection. Began to swell and increase pain that same day. Unable to move arm L. Applied ice on/off for 15 min each time. Pain and swelling lasted 6-7 days.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash), VACCINATION SITE WARMTH (Warm) and DRY SKIN (Feels little dry) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE RASH (rash). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Warm) and DRY SKIN (Feels little dry). At the time of the report, VACCINATION SITE RASH (rash), VACCINATION SITE WARMTH (Warm) and DRY SKIN (Feels little dry) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication include medication for Blood pressure, Cholesterol, Anxiety and Calcium suppliments.  No treatment information was provided
About 10 day afterwards she got severe itching; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Mar-2021 and was forwarded to Moderna on 06-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (About 10 day afterwards she got severe itching) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (About 10 day afterwards she got severe itching). At the time of the report, PRURITUS (About 10 day afterwards she got severe itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.  No treatment medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up information received on 13-Jul-2021 contains no new information.
urinated on herself; everything went black; broke out in sweats; felt her heart "go down to her feet"/petrified; petrified/felt like she was dying; getting nauseated; This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (urinated on herself), DIZZINESS (everything went black), HYPERHIDROSIS (broke out in sweats), FEELING ABNORMAL (felt her heart "go down to her feet"/petrified) and FEAR (petrified/felt like she was dying) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K10-2A and 012C20A or 012C70A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included GERD, Blood pressure, High cholesterol and Hypothyroidism. Concomitant products included DENOSUMAB (XGEVA) for Osteoporosis, NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), OLMESARTAN, LEVOTHYROXINE SODIUM (SYNTHROID), ROSUVASTATIN CALCIUM (CRESTOR), AMLODIPINE and FAMOTIDINE for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced DYSURIA (urinated on herself), DIZZINESS (everything went black), HYPERHIDROSIS (broke out in sweats), FEELING ABNORMAL (felt her heart "go down to her feet"/petrified), FEAR (petrified/felt like she was dying) and NAUSEA (getting nauseated). At the time of the report, DYSURIA (urinated on herself), DIZZINESS (everything went black), HYPERHIDROSIS (broke out in sweats), FEELING ABNORMAL (felt her heart "go down to her feet"/petrified), FEAR (petrified/felt like she was dying) and NAUSEA (getting nauseated) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The caller reported no known drug or food allergies.   She did report she switched from Prolia to Xgeva to treat osteoporosis because her doctor suspected she may have an allergy to latex, but it is unknown.   This case was linked to MOD-2021-346435 (Patient Link).
This spontaneous report as received from an office manager (healthcare worker) refers to a 15 months old male patient. The patient was vaccinated with a dose of M-M-R II (lot # reported as 0667245/0961Z, expiration date 21-JUL-2012) on 25-JUL-2012. It was reported that the patient was vaccinated with expired M-M-R II. No adverse effects reported. Whether the patient sought for medical attention was not reported. The outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
- pain, swelling and welts on the arm (vaccine area) and neck on the same side - fever and headache - nausea - desire to vomit, but without event - stomach pain and swelling without meteorism - fulminant diarrhea - fainting (with loss of consciousness) 15 hrs. after administration of the vaccine  No treatments, as it occurred at around 4 am in the morning.  Except for fainting, all the other symptoms continue as per the time of this sheet being completed/submitted.
I do not know if there is any relationship with the shot and my symptoms, but the timing is suspicious.   Additionally I know of no other reason for the adverse symptoms. About a week after the second dose of the Moderna, both my shoulders started to hurt and my wrists and back side of my hands, especially the thumb areas, swelled and hurt.  By March 1st the pain and swelling  was so bad that I saw a rheumatologist.  He did testing and I am currently taking 5 mg prednisone daily and 200 mg Hydroxichloroquine twice daily.  As of June 16, 2021 the swelling is finally gone as is the pain.  I have a follow-up appointment with a doctor on Monday, June 28, 2021.
No additional AEs reported; Administration of vaccines involved in a tempertature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On 16-FEB-2022, the patient was vaccinated with one dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) which experienced a temperature excursion (lot # U024090 with an expiration date on 28-OCT-2023) for prophylaxis (product storage error) (strength, anatomical location, and route of administration were not reported).    The dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) was exposed to a temperature excursion of 1.35°C degrees Celsius (°C) during a time frame of 1 hour.  No additional adverse events were reported.
PAIN AT SITE OF INJECTION, IMMOBILITY OF  LEFT ARM. CAN'T LIFT OR USE THE LEFT ARM. SHE WENT TO ER AND FAMILY DOCTOR, BUT THEY DID NOT GIVE ANY TREATMENT.
3-4 days post iz, developed sore throat and tiredness. Shot contained 3-4 days and then started bouts of diarrhea and decreased appetite. No fever noted. Resolved 10-11 days later.
1 week pregnant/ 5 weeks pregnant; This spontaneous prospective pregnancy case was reported by a pharmacist and describes the occurrence of EXPOSURE DURING PREGNANCY (1 week pregnant/ 5 weeks pregnant) in a 29-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 011J20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (Prior history of alcohol use ocassionally). Concomitant products included PARACETAMOL (TYLENOL) for Pain, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 29-Dec-2020 and the estimated date of delivery was 05-Oct-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (1 week pregnant/ 5 weeks pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fifth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (1 week pregnant/ 5 weeks pregnant) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Ultrasound scan: (normal) Normal Pregnancy.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details was not reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Pregnancy details updated.
My Left arm has a coin sized raised red and hard circle around the injection site it is warm to the touch and it itches when I put a cold compress on it that helps but as soon as I take it off it looks the same as before. On Saturday morning 04/10/2021 my underarm were my lymph nodes are was swollen and sore to the touch that swelling has gone down it was a little sore until Monday 04/12/2021.
Patient contacted office to report reaction and was seen on 06/01/2021. Patient reported left arm pain at injection site, limited range of motion, shooting pains radiating to left elbow. Patient has tried hot/ cold therapy, over the counter medications, and at home physical therapy without the help of a professional with no significant improvement in symptoms.   Patient was prescribed Meloxicam 15mg 1 daily for 15 days. If no improvements with medication will refer to neurology for further evaluation.
Sick; Neither one of us can even lift our heads; we had high temperatures up to 112; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 80 year-old male patient received bnt162b2 (BNT162B2), administration date 26Jul2021 (Lot number: EW0170) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "Sick"; HYPOKINESIA (non-serious), outcome "unknown", described as "Neither one of us can even lift our heads"; PYREXIA (non-serious), outcome "unknown", described as "we had high temperatures up to 112". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of illness, hypokinesia, pyrexia.  Additional information: This report was reported by the wife of the patient.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100991739 similar report from same reporter
I received the shot on  a Thur afternoon, next morning-extreme fatigue; Friday Afternoon/4:00 onset of fever, which reached to 103.1; I started taking Aleve at 101 degrees, no change within an hour, so took a Tylenol Extra Strength; began using an ice pack behind my neck at 102 degrees; fever started to lower by 8:00 that evening; Saturday was a very fatigue filled day, no energy, sat or layer around all day; Sunday AM, woke up with a rash on my L Arm, site of injection, warm to touch, itchy; soreness increased?had it from just immediately after the injection
On 7/31/02, it was reported "local reaction approx 3 inches in diameter, red warm swollen, fifth dose of series. Dose administered deltoid. Male child, age not indicated right now. Additional info will be given upon request from manufacturer. This doctor has additional similar incidents to report."
Tingling in arm, heart racing 128/80, 80, 18 Patient refused transport informed to follow up with PCP if symptoms continue
Pt received ADACEL inj. to Rt upper arm and one day later hard softball size redness. This did decrease in size to quarter size but abscess developed at inj. site with small area medical with sl. lymphangitis. Needed drained and antibiotics.
Pain and swelling at site within an hour of injection, woke up from sleep around 1am from pain and headache , had to take ibuprofen, swelling and warmth at site was noted. since that time swelling and warmth at site has increased, extremely tender to touch. Pain and swelling with red rash increased during the night of 04.26.2019 to where I couldn't lay on that side.
Injection given too early. First dose administered 1/25/21; second dose administered 2/5/2021
Violent chills started @ 11:00pm. Nauseated around 12:00 AM. Started vomiting ~ 12:15ish and continued thru morning. Severe headache and muscle achiness. Stayed in bed 24 hrs... sleeping most of the day and slept thru the night.
2nd dose: made her feel really energetic; 2nd dose: made her feel really energetic; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single), for COVID-19 immunization, reaction(s): "Diarrhea", "soreness in her arm", "Fever". The following information was reported: ENERGY INCREASED (non-serious), THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown" and all described as "2nd dose: made her feel really energetic".  Additional information: Reporter stated that her mother-in-law (patient) said that the 2nd dose made her like speedy gonzalez; clarified that made her really energetic.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I developed tinnitus about two weeks after getting the shot and it?s been 4 months now and there are no signs of it slowing down.  I have not had any hearing problems prior to getting the booster.
A non-serious spontaneous report of FLUMIST administered to a 54 year old patient was received from a pharmacist concerning a 54-year-old patient. Neither relevant medical history nor concomitant medications had been reported for this patient. An adverse event was reported regarding a 54-year-old patient receiving FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
pt recvd 2nd dose of Hep B vax 12JUL89 & exp. weakness,confusion,& h/a w/ motion sickness.On 14AUG89 pt exp. joint aches & burning in calves.Exam revealed mild scoliosis & degenerative changes.
Information has been received from a registered nurse concerning a 12 year old female with no medical history and no drug allergies, who "one month ago" was vaccinated with a first dose of GARDASIL.  There was no concomitant medication.  Subsequently, the patient experienced prolonged migraine headaches.  The patient was seen by her physician.  At the time of the report, the patient had not recovered.  No product quality complaint was involved.  Additional information has been requested.
This spontaneous report was received from a nurse practitioner who was reporting on a 1 year old female patient. The patient's concurrent conditions, medical history and concomitant medicines were unspecified. On an unknown, date approximately in 2013 (reported as at her 1 year visit), the patient the was vaccinated with measles-mumps-rubella and varicella virus vaccine (manufacturer unknown) with first dose at her first year visit. It was not known if the patient had received Oka/Merck VARIVAX (dose, unit, route of administration, #lot and expiration date were not reported) and (wistar ra 27-3) M-M-R II (dose, unit, route of administration, #lot and expiration date were not reported) or Oka-Merck PROQUAD (dose, unit, route of administration, #lot and expiration date were not reported) at this visits for prophylaxis. On an unknown date, approximately in 2016, the patient the was vaccinated with measles-mumps-rubella and varicella vaccinations (manufacturer unknown) with second dose at her fourth year visit. It was not known if the patient had received Oka/Merck VARIVAX (dose, unit, route of administration, #lot and expiration date were not reported) and (wistar ra 27-3) M-M-R II (dose, unit, route of administration, #lot and expiration date were not reported) or Oka-Merck PROQUAD (dose, unit, route of administration, #lot and expiration date were not reported) at these visits for prophylaxis. On 17-AUG-2018, at her 6 years check up, the patient was vaccinated with a dose of Oka-Merck PROQUAD third dose (dose, unit, route of administration, lot# and expiration date were not reported) reconstituted in sterile diluent (manufacture unknown) for prophylaxis. No adverse effects were noted.
Patient came in and stated that her upper left arm is sore from a flu shot given to her at our location on October 16, 2019. She has come in before but has not complained of the soreness. However, as of late, patient states that her arm is more noticeably sore especially when sleeping on that arm. I recommended some heat and ice and some over-the-counter pain medications if needed to help with the soreness and that I would contact her doctor for further recommendations and to check to see if there are other preexisting issues that may cause soreness. I have not heard back from the doctor after leaving several messages. I have also followed up with patient to see if there has been any improvement or lack there of and no response thus far after initial complaint.
pt stated he did not receive any prior covid vaccines however after dose 1 moderna on 4/26, a vaccination card was found in pts walker basket that indicated he received Jansen on 4/2 at Facility Narrative: